Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 5 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | yes | yes: 8, no: 4 |
NetGPI | no | yes: 0, no: 12 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 3 |
GO:0110165 | cellular anatomical entity | 1 | 3 |
Related structures:
AlphaFold database: Q4QDB9
Term | Name | Level | Count |
---|---|---|---|
GO:0000413 | protein peptidyl-prolyl isomerization | 7 | 3 |
GO:0006457 | protein folding | 2 | 3 |
GO:0006807 | nitrogen compound metabolic process | 2 | 3 |
GO:0008152 | metabolic process | 1 | 3 |
GO:0009987 | cellular process | 1 | 3 |
GO:0018193 | peptidyl-amino acid modification | 5 | 3 |
GO:0018208 | peptidyl-proline modification | 6 | 3 |
GO:0019538 | protein metabolic process | 3 | 3 |
GO:0036211 | protein modification process | 4 | 3 |
GO:0043170 | macromolecule metabolic process | 3 | 3 |
GO:0043412 | macromolecule modification | 4 | 3 |
GO:0044238 | primary metabolic process | 2 | 3 |
GO:0061077 | chaperone-mediated protein folding | 3 | 3 |
GO:0071704 | organic substance metabolic process | 2 | 3 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 3 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003755 | peptidyl-prolyl cis-trans isomerase activity | 3 | 13 |
GO:0003824 | catalytic activity | 1 | 13 |
GO:0016853 | isomerase activity | 2 | 13 |
GO:0016859 | cis-trans isomerase activity | 3 | 13 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 13 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 109 | 111 | PF00675 | 0.338 |
CLV_NRD_NRD_1 | 70 | 72 | PF00675 | 0.430 |
CLV_PCSK_KEX2_1 | 109 | 111 | PF00082 | 0.338 |
CLV_PCSK_KEX2_1 | 70 | 72 | PF00082 | 0.431 |
CLV_PCSK_SKI1_1 | 184 | 188 | PF00082 | 0.329 |
CLV_PCSK_SKI1_1 | 50 | 54 | PF00082 | 0.554 |
DOC_CYCLIN_yCln2_LP_2 | 134 | 140 | PF00134 | 0.265 |
DOC_PP2B_LxvP_1 | 134 | 137 | PF13499 | 0.302 |
DOC_USP7_MATH_1 | 55 | 59 | PF00917 | 0.413 |
DOC_USP7_UBL2_3 | 144 | 148 | PF12436 | 0.281 |
DOC_WW_Pin1_4 | 108 | 113 | PF00397 | 0.352 |
LIG_14-3-3_CanoR_1 | 3 | 8 | PF00244 | 0.556 |
LIG_14-3-3_CanoR_1 | 38 | 43 | PF00244 | 0.400 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.369 |
LIG_Clathr_ClatBox_1 | 65 | 69 | PF01394 | 0.308 |
LIG_FHA_1 | 14 | 20 | PF00498 | 0.499 |
LIG_FHA_2 | 172 | 178 | PF00498 | 0.319 |
LIG_LIR_Apic_2 | 89 | 95 | PF02991 | 0.217 |
LIG_LIR_Gen_1 | 130 | 140 | PF02991 | 0.278 |
LIG_LIR_Gen_1 | 198 | 202 | PF02991 | 0.452 |
LIG_LIR_Gen_1 | 41 | 48 | PF02991 | 0.410 |
LIG_LIR_Nem_3 | 130 | 136 | PF02991 | 0.274 |
LIG_LIR_Nem_3 | 198 | 202 | PF02991 | 0.452 |
LIG_LIR_Nem_3 | 41 | 45 | PF02991 | 0.416 |
LIG_OCRL_FandH_1 | 3 | 15 | PF00620 | 0.362 |
LIG_PDZ_Class_1 | 197 | 202 | PF00595 | 0.414 |
LIG_SH2_CRK | 42 | 46 | PF00017 | 0.314 |
LIG_SH2_CRK | 92 | 96 | PF00017 | 0.217 |
LIG_SH2_NCK_1 | 42 | 46 | PF00017 | 0.314 |
LIG_SH2_SRC | 133 | 136 | PF00017 | 0.311 |
LIG_SH2_STAP1 | 88 | 92 | PF00017 | 0.217 |
LIG_SH2_STAT5 | 133 | 136 | PF00017 | 0.323 |
LIG_SH2_STAT5 | 181 | 184 | PF00017 | 0.450 |
LIG_SH2_STAT5 | 199 | 202 | PF00017 | 0.422 |
LIG_SH2_STAT5 | 47 | 50 | PF00017 | 0.375 |
LIG_SH2_STAT5 | 88 | 91 | PF00017 | 0.244 |
LIG_SUMO_SIM_anti_2 | 16 | 21 | PF11976 | 0.401 |
LIG_SUMO_SIM_par_1 | 23 | 28 | PF11976 | 0.364 |
LIG_TYR_ITIM | 197 | 202 | PF00017 | 0.446 |
MOD_CK1_1 | 171 | 177 | PF00069 | 0.393 |
MOD_CK1_1 | 30 | 36 | PF00069 | 0.432 |
MOD_CK1_1 | 6 | 12 | PF00069 | 0.484 |
MOD_CK2_1 | 171 | 177 | PF00069 | 0.374 |
MOD_GlcNHglycan | 168 | 171 | PF01048 | 0.538 |
MOD_GlcNHglycan | 174 | 177 | PF01048 | 0.337 |
MOD_GlcNHglycan | 57 | 60 | PF01048 | 0.317 |
MOD_GlcNHglycan | 61 | 64 | PF01048 | 0.341 |
MOD_GSK3_1 | 168 | 175 | PF00069 | 0.383 |
MOD_GSK3_1 | 2 | 9 | PF00069 | 0.462 |
MOD_GSK3_1 | 23 | 30 | PF00069 | 0.449 |
MOD_GSK3_1 | 55 | 62 | PF00069 | 0.449 |
MOD_N-GLC_1 | 55 | 60 | PF02516 | 0.418 |
MOD_NEK2_1 | 86 | 91 | PF00069 | 0.271 |
MOD_PIKK_1 | 110 | 116 | PF00454 | 0.407 |
MOD_PKA_2 | 2 | 8 | PF00069 | 0.578 |
MOD_Plk_1 | 27 | 33 | PF00069 | 0.413 |
MOD_Plk_1 | 55 | 61 | PF00069 | 0.424 |
MOD_Plk_4 | 13 | 19 | PF00069 | 0.398 |
MOD_Plk_4 | 27 | 33 | PF00069 | 0.341 |
MOD_Plk_4 | 6 | 12 | PF00069 | 0.496 |
MOD_ProDKin_1 | 108 | 114 | PF00069 | 0.352 |
MOD_SUMO_rev_2 | 145 | 153 | PF00179 | 0.249 |
TRG_DiLeu_BaEn_1 | 121 | 126 | PF01217 | 0.244 |
TRG_ENDOCYTIC_2 | 133 | 136 | PF00928 | 0.233 |
TRG_ENDOCYTIC_2 | 199 | 202 | PF00928 | 0.592 |
TRG_ENDOCYTIC_2 | 42 | 45 | PF00928 | 0.383 |
TRG_ER_diArg_1 | 108 | 110 | PF00400 | 0.312 |
TRG_NES_CRM1_1 | 114 | 128 | PF08389 | 0.360 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HTT4 | Leptomonas seymouri | 30% | 100% |
A0A0N1II12 | Leptomonas seymouri | 65% | 100% |
A0A1X0P7N1 | Trypanosomatidae | 40% | 95% |
A0A3S5H764 | Leishmania donovani | 96% | 100% |
A0A3S5IR72 | Trypanosoma rangeli | 39% | 100% |
A4H677 | Leishmania braziliensis | 30% | 100% |
A4HA48 | Leishmania braziliensis | 77% | 99% |
A4HYB4 | Leishmania infantum | 96% | 100% |
D0A0P0 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 34% | 100% |
E9AN99 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 28% | 100% |
E9AS47 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 90% | 100% |
Q09734 | Trypanosoma cruzi | 38% | 100% |
Q4QHC5 | Leishmania major | 28% | 100% |
Q9JYI8 | Neisseria meningitidis serogroup B (strain MC58) | 28% | 74% |